Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
PUT
Zoetis
ZTS
$30.8B
| $17.8M | 0.01% |
129,800
-8,600
| -6% | -$1.12M |
|
1502
Westlake Corp
WLK
$10.2B
| $17.8M | 0.01% |
331,239
+114,181
| +53% | +$5.26M |
|
1503
CALL
Digital Realty Trust
DLR
$73.9B
| $17.7M | 0.01% |
124,800
-54,700
| -30% | -$7.74M |
|
1504
PUT
Five Below
FIVE
$13.5B
| $17.7M | 0.01% |
165,700
-64,700
| -28% | -$6.07M |
|
1505
Qualys
QLYS
$6.58B
| $17.6M | 0.01% |
169,554
+73,355
| +76% | +$7.69M |
|
1506
Deckers Outdoor
DECK
$12.7B
| $17.6M | 0.01% |
538,704
+151,908
| +39% | +$4.19M |
|
|
XLRN
1507
DELISTED
Acceleron Pharma
XLRN
| $17.6M | 0.01% |
185,083
+144,019
| +351% | +$13.9M |
|
1508
Neurocrine Biosciences
NBIX
$15.6B
| $17.6M | 0.01% |
144,355
-852,854
| -86% | -$94.2M |
|
1509
CALL
Keysight
KEYS
$60.9B
| $17.6M | 0.01% |
174,700
+22,600
| +15% | +$2.22M |
|
|
CYBR
1510
PUT
DELISTED
CyberArk
CYBR
| $17.6M | 0.01% |
177,300
+20,400
| +13% | +$1.99M |
|
1511
PUT
Shake Shack
SHAK
$3.01B
| $17.6M | 0.01% |
332,200
-33,900
| -9% | -$1.71M |
|
1512
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
| $17.6M | 0.01% |
192,059
-256,806
| -57% | -$23.5M |
|
1513
CALL
Progressive
PGR
$123B
| $17.6M | 0.01% |
219,200
+12,300
| +6% | +$960K |
|
1514
FIVE9
FIVN
$2.45B
| $17.5M | 0.01% |
158,447
-82,207
| -34% | -$8M |
|
1515
PUT
Molson Coors Class B
TAP
$7.91B
| $17.5M | 0.01% |
509,500
+359,400
| +239% | +$14.3M |
|
|
PRVL
1516
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $17.5M | 0.01% |
1,174,663
+2,866
| +0.2% | +$44.1K |
|
1517
Icon
ICLR
$12.6B
| $17.5M | 0.01% |
103,855
+1,464
| +1% | +$231K |
|
1518
CALL
Tilray
TLRY
$624M
| $17.5M | 0.01% |
246,000
+27,880
| +13% | +$2.25M |
|
1519
CALL
Hilton Worldwide
HLT
$73.4B
| $17.5M | 0.01% |
238,100
-155,600
| -40% | -$11.5M |
|
1520
CALL
ProShares UltraPro S&P 500
UPRO
$5.81B
| $17.5M | 0.01% |
788,200
+298,600
| +61% | +$5.8M |
|
1521
Global X MLP & Energy Infrastructure ETF
MLPX
$3.61B
| $17.5M | 0.01% |
+702,583
| New | +$16.9M |
|
1522
CALL
AGNC Investment
AGNC
$13B
| $17.5M | 0.01% |
1,353,100
+960,300
| +244% | +$12M |
|
1523
PagerDuty
PD
$918M
| $17.4M | 0.01% |
609,310
+581,983
| +2,130% | +$14M |
|
1524
PUT
Huntington Ingalls Industries
HII
$12.9B
| $17.4M | 0.01% |
99,900
+82,200
| +464% | +$15.3M |
|
|
1525
PUT
Fidelity National Information Services
FIS
$22.2B
| $17.4M | 0.01% |
129,900
+10,300
| +9% | +$1.35M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.